Vancouver, British Columbia, and Rehovot, Israel–(Newsfile Corp. – October 7, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or the “Company”) is pleased...
VINIA® sales orders reached a record high of USD 1.71M representing 145% growth compared to Q3 2021 and 81% growth compared to Q2 2022 Q3 Sales...
The award recognizes the sustainability impact of BioHarvest’s Bio Plant CELLicitation technology, which enables industrial production of plant metabolites without growing the plant itself BioHarvest Sciences...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – August 18, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) has...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – July 18, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) “)...
Purchase order of 1,000 kg for prompt delivery to support the growing demand for VINIA® Pipeline of 6 major customers testing VINIA® for inclusion in their...
VINIA® sales orders reached a record high of USD 947k representing 99% growth compared to Q2 2021 and 24% growth compared to Q1 2022 BioHarvest reiterates...
Gavriel Lambert’s 27 years of investment banking experience, covering the consumer and retail sectors and working on numerous capital markets transactions including IPOs, financings and M&A,...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – June 24, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or “the Company”) invites its shareholders and the general...
Move confirms the Company’s commitment to bring to market scientific and clinically based therapeutic solutions derived from plants and sets the path for the development of...